当前位置: 化药新药研发 > 方案详情

苯磺酸氨氯地平中从HPLC转移至UHPLC检测方案(液相色谱仪)

检测样品 化药新药研发

检测项目 从HPLC转移至UHPLC

关联设备 共1种 下载方案

方案详情

Over the last decades, an increasing number of generic drug formulations have been released on the pharmaceutical market. These products are generally analyzed with compendia methods. This Application Note describes the method transfer of a USP HPLC method for amlodipine besylate tablets to a state-of-the-art UHPLC method. Adjustments on column dimension and method parameters were carried out within the permitted limits in order to avoid the need for a lengthy revalidation process. The Agilent 1290 Infinity II LC facilitated smooth transfer from one method to the other. System suitability criteria were investigated and met with both HPLC and UHPLC.

智能文字提取功能测试中

关闭

产品配置单

安捷伦科技(中国)有限公司为您提供《苯磺酸氨氯地平中从HPLC转移至UHPLC检测方案(液相色谱仪)》,该方案主要用于化药新药研发中从HPLC转移至UHPLC检测,参考标准《暂无》,《苯磺酸氨氯地平中从HPLC转移至UHPLC检测方案(液相色谱仪)》用到的仪器有Agilent 1290 Infinity II 液相色谱系统。

我要纠错

推荐专场

相关方案